https://medicaex.com/businesswire/global-rehabilitation-equipment-market-analysis-report-2022-2027-integration-of-iot-in-rehabilitation-equipment-growth-potential-in-emerging-countries-growing-focus-on-organic-growth-strategi/ 2022-12-02T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-9dY090.jpeg https://medicaex.com/businesswire/global-bacteriophage-therapy-market-report-2022-looming-threat-of-antimicrobial-resistance-drives-research-growth-researchandmarkets-com/ 2022-12-02T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-BXtmLz.jpeg https://medicaex.com/businesswire/rna-sequencing-services-market-2035-researchandmarkets-com/ 2022-12-02T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-dTUJbu.jpeg https://medicaex.com/businesswire/sinus-dilation-devices-market-report-2022-a-3-8-billion-global-market-by-2027-focus-on-balloon-dilation-devices-endoscopes-and-handheld-rhinoscope-sinoscope-researchandmarkets-com-2/ 2022-12-02T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-mgAQHZ.jpeg https://medicaex.com/businesswire/global-pulmonary-drug-delivery-devices-market-report-to-2031-players-include-boehringer-ingelheim-novartis-mylan-and-3m-researchandmarkets-com-3/ 2022-12-02T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-UwFYih.jpeg https://medicaex.com/businesswire/sinus-dilation-devices-market-report-2022-a-3-8-billion-global-market-by-2027-focus-on-balloon-dilation-devices-endoscopes-and-handheld-rhinoscope-sinoscope-researchandmarkets-com/ 2022-12-02T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-wj7frw.jpeg https://medicaex.com/businesswire/global-pulmonary-drug-delivery-devices-market-report-to-2031-players-include-boehringer-ingelheim-novartis-mylan-and-3m-researchandmarkets-com-2/ 2022-12-02T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-r5IYer.jpeg https://medicaex.com/businesswire/global-pulmonary-drug-delivery-devices-market-report-to-2031-players-include-boehringer-ingelheim-novartis-mylan-and-3m-researchandmarkets-com/ 2022-12-02T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-xIzR4C.jpeg https://medicaex.com/businesswire/scientists-develop-12-hour-method-to-predict-diabetes-onset-in-patients-using-artificial-intelligence/ 2022-12-02T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Klick-Applied_Sciences_Logo_Final_Vertical403x-100_28129-0S8xQO.jpeg https://medicaex.com/businesswire/stoke-therapeutics-presents-data-from-a-combined-interim-analysis-of-the-phase-1-2a-monarch-and-admiral-studies-of-stk-001-in-children-and-adolescents-with-dravet-syndrome-at-the-american-epilepsy-s-2/ 2022-12-02T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Stoke_Logo1_-_CMYK_50percent-t5zFWM.jpeg https://medicaex.com/businesswire/incyte-and-cms-announce-collaboration-and-license-agreement-for-ruxolitinib-cream-in-greater-china-and-southeast-asia-2/ 2022-12-02T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Incyte_Color_Logo_JPEG_282_Color_Positive29-TFivNN.jpeg https://medicaex.com/businesswire/global-artificial-intelligence-in-medical-diagnostics-market-report-to-2029-growing-number-of-cross-industry-partnerships-collaborations-present-opportunities-researchandmarkets-com/ 2022-12-02T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-WCYrcn.jpeg https://medicaex.com/businesswire/cisco-investments-and-third-culture-capital-among-notable-investors-in-voiceitts-latest-funding-round-to-scale-its-accessible-speech-recognition/ 2022-12-02T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/Ensemble_white_28129-olgzLJ.jpeg https://medicaex.com/businesswire/quill-com-recognized-as-one-of-americas-best-customer-service-companies-by-newsweek-2/ 2022-12-02T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/Quill_Logo-P10FAP.jpeg https://medicaex.com/businesswire/global-medical-lifting-sling-market-research-report-2022-to-2028-players-include-benmor-medical-cortland-etac-and-gunnebo-industries-researchandmarkets-com/ 2022-12-02T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-gDcFw0.jpeg https://medicaex.com/businesswire/quill-com-recognized-as-one-of-americas-best-customer-service-companies-by-newsweek/ 2022-12-02T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Quill_Logo-GkQ5Xf.jpeg https://medicaex.com/businesswire/stoke-therapeutics-presents-data-from-a-combined-interim-analysis-of-the-phase-1-2a-monarch-and-admiral-studies-of-stk-001-in-children-and-adolescents-with-dravet-syndrome-at-the-american-epilepsy-soc/ 2022-12-02T14:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/Stoke_Logo1_-_CMYK_50percent-dcGjuh.jpeg https://medicaex.com/businesswire/incyte-and-cms-announce-collaboration-and-license-agreement-for-ruxolitinib-cream-in-greater-china-and-southeast-asia/ 2022-12-02T14:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/Incyte_Color_Logo_JPEG_282_Color_Positive29-P4kqBc.jpeg https://medicaex.com/businesswire/iveric-bio-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/ 2022-12-02T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Iveric_Bio_Logo-6jDdcS.jpeg https://medicaex.com/businesswire/2022-insights-on-biotechnology-companies-in-china-biotechnology-pharmaceutical-producer-profiles-and-directory-researchandmarkets-com/ 2022-12-02T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-BYyi64.jpeg https://medicaex.com/businesswire/asia-pacific-infant-child-and-maternal-probiotic-supplements-market-report-2022-growing-awareness-regarding-benefits-of-probiotic-supplements-among-pregnant-women-fuels-sector-researchandmarkets/ 2022-12-02T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-lj5s51.jpeg https://medicaex.com/businesswire/iveric-bio-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/ 2022-12-02T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Iveric_Bio_Logo-qdQJB7.jpeg https://medicaex.com/businesswire/adicet-bio-to-host-investor-webcast-to-discuss-updated-clinical-data-from-ongoing-adi-001-phase-1-trial-in-patients-with-relapsed-or-refractory-aggressive-b-cell-non-hodgkins-lymphoma-nhl-2/ 2022-12-02T12:12:09+00:00 https://medicaex.com/businesswire/the-worldwide-healthcare-provider-network-management-industry-is-expected-to-reach-8-billion-by-2027-researchandmarkets-com/ 2022-12-02T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-wNxMIg.jpeg https://medicaex.com/businesswire/human-factors-usability-studies-following-iso-62366-and-the-new-fda-guidance-webinar-researchandmarkets-com/ 2022-12-02T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-x8QNgt.jpeg https://medicaex.com/businesswire/adicet-bio-to-host-investor-webcast-to-discuss-updated-clinical-data-from-ongoing-adi-001-phase-1-trial-in-patients-with-relapsed-or-refractory-aggressive-b-cell-non-hodgkins-lymphoma-nhl/ 2022-12-02T12:12:04+00:00 https://medicaex.com/businesswire/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com/ 2022-12-02T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-eeEbgZ.jpeg https://medicaex.com/businesswire/mirna-sequencing-and-assay-market-report-2022-rise-in-adoption-of-rna-sequencing-protocols-in-biotechnology-research-drives-growth-researchandmarkets-com/ 2022-12-02T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-aCSSkY.jpeg https://medicaex.com/businesswire/bio-thera-solutions-announces-presentation-of-bat8009-b7-h3-adc-at-the-2nd-annual-adc-target-selection-summit-2/ 2022-12-02T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/New_Bio-Thera_Logo-YnQXAF.jpeg https://medicaex.com/businesswire/bio-thera-solutions-announces-bat8006-folate-receptor-%ce%b1-adc-and-bat8008-trop2-adc-poster-presentations-at-the-2022-san-antonio-breast-cancer-symposium-2/ 2022-12-02T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/New_Bio-Thera_Logo-ieCapm.jpeg https://medicaex.com/businesswire/medical-foods-global-market-to-reach-24-11-billion-by-2026-at-a-cagr-of-5-61-researchandmarkets-com/ 2022-12-02T11:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-UdnInJ.jpeg https://medicaex.com/businesswire/the-worldwide-urinalysis-industry-is-expected-to-reach-5-3-billion-by-2031-researchandmarkets-com/ 2022-12-02T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-gDevLF.jpeg https://medicaex.com/businesswire/bio-thera-solutions-announces-presentation-of-bat8009-b7-h3-adc-at-the-2nd-annual-adc-target-selection-summit/ 2022-12-02T11:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/New_Bio-Thera_Logo-60wvDT.jpeg https://medicaex.com/businesswire/bio-thera-solutions-announces-bat8006-folate-receptor-%ce%b1-adc-and-bat8008-trop2-adc-poster-presentations-at-the-2022-san-antonio-breast-cancer-symposium/ 2022-12-02T11:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/New_Bio-Thera_Logo-nzGJ2e.jpeg https://medicaex.com/businesswire/global-hepatitis-b-vaccines-market-to-reach-3-4-billion-by-2027-researchandmarkets-com/ 2022-12-02T10:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-0LWiwE.jpeg https://medicaex.com/businesswire/shi-receives-first-order-for-next-generation-proton-therapy-system-from-taichung-veterans-general-hospital/ 2022-12-02T07:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/SUMITOMO_photo-fWDiRZ.jpeg https://medicaex.com/businesswire/urogen-announces-new-data-from-the-olympus-trial-that-shows-median-durability-of-response-of-28-9-months-for-jelmyto-the-only-non-surgical-chemoablative-treatment-for-adults-with-low-grade-upp-2/ 2022-12-02T00:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/UroGen_logo2_28R29_2800229-Q5VdZA.jpeg https://medicaex.com/businesswire/urogen-announces-new-data-from-the-olympus-trial-that-shows-median-durability-of-response-of-28-9-months-for-jelmyto-the-only-non-surgical-chemoablative-treatment-for-adults-with-low-grade-upp/ 2022-12-02T00:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/UroGen_logo2_28R29_2800229-gIMFBC.jpeg https://medicaex.com/businesswire/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago-3/ 2022-12-01T23:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/kristen-updated-headshot_28129-jmpesp.jpeg https://medicaex.com/businesswire/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago-2/ 2022-12-01T23:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/kristen-updated-headshot_28129-cLZDqn.jpeg https://medicaex.com/businesswire/merges-dr-kirsten-ambegaokar-named-to-mmms-40-under-40-list-chicago/ 2022-12-01T23:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/kristen-updated-headshot_28129-XFMpkT.jpeg https://medicaex.com/businesswire/blue-earth-diagnostics-announces-efficacy-and-safety-results-from-phase-3-lighthouse-trial-of-investigational-pet-imaging-agent-18f-rhpsma-7-3-in-newly-diagnosed-prostate-cancer-3/ 2022-12-01T22:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/18FrhPSMA7.3_in_newly_diagnosed_PCa_2002101-XuS1MI.jpeg https://medicaex.com/businesswire/otsuka-pharmaceutical-lundbeck-present-positive-data-from-multiple-phase-3-studies-showing-brexpiprazole-significantly-improved-symptoms-of-agitation-in-patients-with-alzheimers-dementi-2/ 2022-12-01T22:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/Otsuka_Logo_Color_RGB-CPQTJf.jpeg https://medicaex.com/businesswire/immunogen-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-4/ 2022-12-01T22:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/imgnlogo-QfN91j.jpeg https://medicaex.com/businesswire/usana-health-sciences-to-participate-in-the-sidoti-virtual-investor-conference/ 2022-12-01T22:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/USNA-239Xzd.jpeg https://medicaex.com/businesswire/blue-earth-diagnostics-announces-efficacy-and-safety-results-from-phase-3-lighthouse-trial-of-investigational-pet-imaging-agent-18f-rhpsma-7-3-in-newly-diagnosed-prostate-cancer-2/ 2022-12-01T22:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/18FrhPSMA7.3_in_newly_diagnosed_PCa_2002101-cGo8d3.jpeg https://medicaex.com/businesswire/otsuka-pharmaceutical-lundbeck-present-positive-data-from-multiple-phase-3-studies-showing-brexpiprazole-significantly-improved-symptoms-of-agitation-in-patients-with-alzheimers-dementi/ 2022-12-01T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/Otsuka_Logo_Color_RGB-xBGQEW.jpeg https://medicaex.com/businesswire/immunogen-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-3/ 2022-12-01T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/imgnlogo-4tOyMF.jpeg https://medicaex.com/businesswire/blue-earth-diagnostics-announces-efficacy-and-safety-results-from-phase-3-lighthouse-trial-of-investigational-pet-imaging-agent-18f-rhpsma-7-3-in-newly-diagnosed-prostate-cancer/ 2022-12-01T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/18FrhPSMA7.3_in_newly_diagnosed_PCa_2002101-vV3n2N.jpeg https://medicaex.com/businesswire/pipeline-therapeutics-announces-participation-in-the-2022-rbc-capital-markets-healthcare-private-company-virtual-conference-2/ 2022-12-01T21:12:10+00:00 https://medicaex.com/businesswire/rocket-pharmaceuticals-completes-acquisition-of-renovacor-2/ 2022-12-01T21:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/Rocket_Pharma-bWV7U3.jpeg https://medicaex.com/businesswire/everest-clinical-research-an-arlington-capital-partners-portfolio-company-announces-the-acquisition-of-brightech-international-3/ 2022-12-01T21:12:10+00:00 https://medicaex.com/businesswire/everest-clinical-research-an-arlington-capital-partners-portfolio-company-announces-the-acquisition-of-brightech-international-2/ 2022-12-01T21:12:07+00:00 https://medicaex.com/businesswire/pipeline-therapeutics-announces-participation-in-the-2022-rbc-capital-markets-healthcare-private-company-virtual-conference/ 2022-12-01T21:12:05+00:00 https://medicaex.com/businesswire/rocket-pharmaceuticals-completes-acquisition-of-renovacor/ 2022-12-01T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/Rocket_Pharma-7WTtl6.jpeg https://medicaex.com/businesswire/everest-clinical-research-an-arlington-capital-partners-portfolio-company-announces-the-acquisition-of-brightech-international/ 2022-12-01T21:12:05+00:00 https://medicaex.com/businesswire/tevogen-bio-to-develop-t-cell-therapies-for-treatment-of-epstein-barr-virus-related-cancers-and-multiple-sclerosis-2/ 2022-12-01T19:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Tevogen_Logo_800px-TenEVC.jpeg https://medicaex.com/businesswire/alsana-st-louis-and-birmingham-offer-annual-grant-for-residential-treatment-2/ 2022-12-01T19:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Alsana_Horiz_Logo_28129-QjuFEu.jpeg https://medicaex.com/businesswire/nanovibronix-announces-closing-of-2-4-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules/ 2022-12-01T19:12:06+00:00 https://medicaex.com/businesswire/tevogen-bio-to-develop-t-cell-therapies-for-treatment-of-epstein-barr-virus-related-cancers-and-multiple-sclerosis/ 2022-12-01T19:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Tevogen_Logo_800px-luJeLb.jpeg https://medicaex.com/businesswire/alsana-st-louis-and-birmingham-offer-annual-grant-for-residential-treatment/ 2022-12-01T19:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/Alsana_Horiz_Logo_28129-z7HrwR.jpeg https://medicaex.com/businesswire/foresite-labs-appoints-ian-tong-md-and-former-stanford-school-of-medicine-professor-as-chief-clinical-officer-2/ 2022-12-01T18:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/ForesiteLabs_Identity_Horizontal_Black_RGB_28129-OuCRKf.jpeg https://medicaex.com/businesswire/foresite-labs-appoints-ian-tong-md-and-former-stanford-school-of-medicine-professor-as-chief-clinical-officer/ 2022-12-01T18:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/ForesiteLabs_Identity_Horizontal_Black_RGB_28129-GfUQvS.jpeg https://medicaex.com/businesswire/advi-health-joins-forces-with-sheridan-capital-partners/ 2022-12-01T18:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/1.advi-logo_283000px29_28229-ECeOGg.jpeg https://medicaex.com/businesswire/carenet-health-acquires-stericycle-communication-solutions-creating-industrys-most-comprehensive-healthcare-consumer-engagement-company/ 2022-12-01T18:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Carenet_infographic-8WtPVz.jpeg https://medicaex.com/businesswire/global-rapid-microbiology-tests-market-report-to-2030-featuring-abbott-laboratories-alere-danaher-and-orasure-technologies-among-others-researchandmarkets-com/ 2022-12-01T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-uBUyai.jpeg https://medicaex.com/businesswire/worldwide-iron-supplements-industry-to-2030-north-america-accounted-for-34-72-share-of-the-global-market-researchandmarkets-com/ 2022-12-01T18:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-Qt3Hr6.jpeg https://medicaex.com/businesswire/lsi-appoints-vice-president-of-business-development-and-vice-president-of-growth-3/ 2022-12-01T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/LSI_Logo_Blue_gradient-DDssed.jpeg https://medicaex.com/businesswire/worldwide-paternity-relationship-testing-services-industry-to-2027-by-application-and-product-researchandmarkets-com-2/ 2022-12-01T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-zrkG9X.jpeg https://medicaex.com/businesswire/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com-2/ 2022-12-01T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-Cv9xD1.jpeg https://medicaex.com/businesswire/lsi-appoints-vice-president-of-business-development-and-vice-president-of-growth/ 2022-12-01T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/LSI_Logo_Blue_gradient-hyjgRN.jpeg https://medicaex.com/businesswire/lsi-appoints-vice-president-of-business-development-and-vice-president-of-growth-2/ 2022-12-01T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/LSI_Logo_Blue_gradient-N3krlt.jpeg https://medicaex.com/businesswire/worldwide-paternity-relationship-testing-services-industry-to-2027-by-application-and-product-researchandmarkets-com/ 2022-12-01T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-ukV6I5.jpeg https://medicaex.com/businesswire/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com/ 2022-12-01T17:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-YczoFA.jpeg https://medicaex.com/businesswire/community-technology-cooperative-ctc-completes-implementation-of-epic-at-ten-massachusetts-health-centers/ 2022-12-01T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/CTC_Logo-KO6WbU.jpeg https://medicaex.com/businesswire/pfizer-invites-public-to-register-for-webcast-of-pfizer-near-term-launches-high-value-pipeline-day-4/ 2022-12-01T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/Pfizer_Logo_Color_RGB_APPROVED-5HzTWS.jpeg https://medicaex.com/businesswire/allonnia-now-capable-of-providing-bench-scale-treatability-studies-for-pfas-contaminated-sites/ 2022-12-01T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/Allonnia-logo-gradient-tm-rgb-JUEzI5.jpeg https://medicaex.com/businesswire/vaxxas-appoints-doug-cubbin-as-chief-financial-officer-2/ 2022-12-01T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/Vaxxas_CFO_Doug_Cubbin-XU0LlL.jpeg https://medicaex.com/businesswire/ventus-therapeutics-presents-an-overview-of-its-nlrp3-inhibitors-at-inflammasome-therapeutics-summit-2/ 2022-12-01T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/High_Res_Logo-ekR77W.jpeg https://medicaex.com/businesswire/insights-on-the-clinical-alarm-management-global-market-to-2028-increasing-use-of-electronic-health-records-is-driving-growth-researchandmarkets-com-2/ 2022-12-01T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-vqY7ul.jpeg https://medicaex.com/businesswire/u-s-surgeon-general-dr-vivek-murthy-joins-calm-to-bring-mental-health-support-ahead-of-the-holidays/ 2022-12-01T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/4._Calm_App_Icon-dZddU5.jpeg https://medicaex.com/businesswire/curve-dental-taps-into-pearls-ai/ 2022-12-01T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Pearl_logo-9IETTP.jpeg https://medicaex.com/businesswire/pfizer-invites-public-to-register-for-webcast-of-pfizer-near-term-launches-high-value-pipeline-day-3/ 2022-12-01T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Pfizer_Logo_Color_RGB_APPROVED-hfLjAi.jpeg https://medicaex.com/businesswire/insights-on-the-clinical-alarm-management-global-market-to-2028-increasing-use-of-electronic-health-records-is-driving-growth-researchandmarkets-com/ 2022-12-01T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-lUaGb3.jpeg https://medicaex.com/businesswire/global-audiology-devices-market-report-2022-to-2028-featuring-siemens-medtronic-gn-store-nord-and-sonova-holding-among-others-researchandmarkets-com/ 2022-12-01T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-Eamz6F.jpeg https://medicaex.com/businesswire/pfizer-invites-public-to-register-for-webcast-of-pfizer-near-term-launches-high-value-pipeline-day-2/ 2022-12-01T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/Pfizer_Logo_Color_RGB_APPROVED-kLcWLn.jpeg https://medicaex.com/businesswire/novel-antibody-therapies-market-2035-researchandmarkets-com/ 2022-12-01T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-t9tFzn.jpeg https://medicaex.com/businesswire/pfizer-invites-public-to-register-for-webcast-of-pfizer-near-term-launches-high-value-pipeline-day/ 2022-12-01T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Pfizer_Logo_Color_RGB_APPROVED-tyTdtF.jpeg https://medicaex.com/businesswire/vaxxas-appoints-doug-cubbin-as-chief-financial-officer/ 2022-12-01T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Vaxxas_CFO_Doug_Cubbin-rDKiiv.jpeg https://medicaex.com/businesswire/ventus-therapeutics-presents-an-overview-of-its-nlrp3-inhibitors-at-inflammasome-therapeutics-summit/ 2022-12-01T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/High_Res_Logo-m7KSVX.jpeg https://medicaex.com/businesswire/shore-quality-partners-teams-with-genomind-to-help-prevent-adverse-prescription-drug-events/ 2022-12-01T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/shore_x_genomind_logos-WKSx9I.jpeg https://medicaex.com/businesswire/counslr-and-allstar-childrens-center-partner-to-offer-24-7-text-based-mental-health-support-to-faculty/ 2022-12-01T15:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/Official2BLogo2B28Purple29-OIGrVL.jpeg https://medicaex.com/businesswire/organ-recovery-systems-lifeport-liver-transporter-preserves-first-livers-for-transplant-as-part-of-the-pilot-continued-access-study-3/ 2022-12-01T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/12/LLT_Video_Thumbnail-sjE4DL.jpeg https://medicaex.com/businesswire/belgian-company-minze-health-raises-e3-9m-to-further-scale-its-digital-health-solutions-for-the-treatment-of-urinary-tract-problems-2/ 2022-12-01T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/12/01_Minze_Diary_Pod-TkjoDW.jpeg https://medicaex.com/businesswire/wuxi-sta-and-multiply-labs-announce-partnership-and-successfully-deploy-robotic-manufacturing-system-for-personalized-drugs/ 2022-12-01T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/12/WuXi_Announcement_Photo-jkVWNe.jpeg https://medicaex.com/businesswire/qurient-announces-dosing-of-first-patient-in-q901-phase-1-2-clinical-study-for-the-treatment-of-patients-with-solid-tumors-2/ 2022-12-01T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/qurient-3YlXP9.jpeg https://medicaex.com/businesswire/good-measures-launches-the-good-food-prescription-program-a-high-impact-scalable-and-comprehensive-food-as-medicine-solution/ 2022-12-01T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/Good_Measures_Horizontal_Logo_RGB_REGISTERED-3NLa4z.jpeg https://medicaex.com/businesswire/the-worldwide-peptide-therapeutics-industry-is-expected-to-reach-58-4-billion-by-2028-researchandmarkets-com/ 2022-12-01T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-qnWazP.jpeg https://medicaex.com/businesswire/pure-barre-and-perfect-bar-partner-in-2023-to-fuel-wellness-with-fresh-snacks-and-fitness/ 2022-12-01T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/PBPBpic-eyc7iV.jpeg https://medicaex.com/businesswire/new-west-life-smoothie-line-blends-convenience-and-soy-powered-energy-now-available-to-shoppers-nationwide/ 2022-12-01T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/West_Logo_noheart-V2ei9a.jpeg https://medicaex.com/businesswire/baxter-introduces-exactamix-pro-next-generation-automated-nutrition-compounder-at-ashp-meeting-5/ 2022-12-01T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/DCO_1301_ExactaMixPro_Remove3Supports_SplashScreen_BlurredBags_Transparent_Black-tbHMeI.jpeg https://medicaex.com/businesswire/oura-launches-oura-for-business-an-evolved-wellness-solution-upgrading-how-organizations-support-their-people-2/ 2022-12-01T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/Oura_For_Business_Logo-OtRbcY.jpeg https://medicaex.com/businesswire/sermo-survey-finds-opportunity-to-educate-general-care-physicians-on-prep-to-increase-patient-adoption-2/ 2022-12-01T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/s158_tl_barometer_281080p29-MlmilH.jpeg https://medicaex.com/businesswire/organ-recovery-systems-lifeport-liver-transporter-preserves-first-livers-for-transplant-as-part-of-the-pilot-continued-access-study-2/ 2022-12-01T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/LLT_Video_Thumbnail-3wM2WE.jpeg https://medicaex.com/businesswire/baxter-introduces-exactamix-pro-next-generation-automated-nutrition-compounder-at-ashp-meeting-4/ 2022-12-01T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/DCO_1301_ExactaMixPro_Remove3Supports_SplashScreen_BlurredBags_Transparent_Black-9MGKpK.jpeg https://medicaex.com/businesswire/oura-launches-oura-for-business-an-evolved-wellness-solution-upgrading-how-organizations-support-their-people/ 2022-12-01T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Oura_For_Business_Logo-GlSgEg.jpeg https://medicaex.com/businesswire/apollo-intelligence-appoints-rey-lado-as-chief-people-officer/ 2022-12-01T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Ai_Logo-2-01_from_MOZ_07-21-2020-toZCSn.jpeg https://medicaex.com/businesswire/organ-recovery-systems-lifeport-liver-transporter-preserves-first-livers-for-transplant-as-part-of-the-pilot-continued-access-study/ 2022-12-01T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/LLT_Video_Thumbnail-cWX1R4.jpeg https://medicaex.com/businesswire/belgian-company-minze-health-raises-e3-9m-to-further-scale-its-digital-health-solutions-for-the-treatment-of-urinary-tract-problems/ 2022-12-01T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/01_Minze_Diary_Pod-Wu4kWa.jpeg https://medicaex.com/businesswire/baxter-introduces-exactamix-pro-next-generation-automated-nutrition-compounder-at-ashp-meeting-3/ 2022-12-01T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/DCO_1301_ExactaMixPro_Remove3Supports_SplashScreen_BlurredBags_Transparent_Black-fT2d5I.jpeg https://medicaex.com/businesswire/baxter-introduces-exactamix-pro-next-generation-automated-nutrition-compounder-at-ashp-meeting-2/ 2022-12-01T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/DCO_1301_ExactaMixPro_Remove3Supports_SplashScreen_BlurredBags_Transparent_Black-EjZCfI.jpeg https://medicaex.com/businesswire/baxter-introduces-exactamix-pro-next-generation-automated-nutrition-compounder-at-ashp-meeting/ 2022-12-01T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/DCO_1301_ExactaMixPro_Remove3Supports_SplashScreen_BlurredBags_Transparent_Black-flRWnb.jpeg https://medicaex.com/businesswire/sermo-survey-finds-opportunity-to-educate-general-care-physicians-on-prep-to-increase-patient-adoption/ 2022-12-01T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/s158_tl_barometer_281080p29-kiIWw2.jpeg https://medicaex.com/businesswire/qurient-announces-dosing-of-first-patient-in-q901-phase-1-2-clinical-study-for-the-treatment-of-patients-with-solid-tumors/ 2022-12-01T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/qurient-s9DTvQ.jpeg https://medicaex.com/businesswire/oscar-health-announces-expansion-with-vanderbilt-university-medical-center-to-provide-in-network-health-coverage-for-residents-across-the-nashville-region/ 2022-12-01T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Oscar_Logo_Blue-sAKhf9.jpeg https://medicaex.com/businesswire/otsuka-and-sunovion-initiate-clinical-development-of-ulotaront-for-the-adjunctive-treatment-of-major-depressive-disorder/ 2022-12-01T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Otsuka_Logo_Color_RGB-XLOH4i.jpeg https://medicaex.com/businesswire/august-bioservices-closes-65m-series-b-2/ 2022-12-01T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/12/AUG_BIO_LOGO_final_TM_FINAL_NEW-o0z7j9.jpeg https://medicaex.com/businesswire/bioaffinity-technologies-presents-proprietary-cancer-therapeutic-research-at-joint-ascb-embo-meeting-2/ 2022-12-01T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/12/bioAfinity_logo-6uinFs.jpeg https://medicaex.com/businesswire/recode-therapeutics-appoints-trisha-millican-to-board-of-directors-2/ 2022-12-01T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/12/ReCode_Logo_Primary_Web402000px-rUC8UC.jpeg https://medicaex.com/businesswire/united-kingdom-food-health-and-wellness-trends-report-2022-consumers-search-for-living-eating-healthier-in-this-period-of-tumultuous-change-and-challenge-researchandmarkets-com/ 2022-12-01T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-gjS0cv.jpeg https://medicaex.com/businesswire/new-crown-bioscience-publication-details-application-of-in-vitro-3d-organoids-with-matched-pdx-for-clinically-relevant-oncology-drug-development-3/ 2022-12-01T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/Crown_Bioscience_Logo_-_TEAL-Fj6Ye7.jpeg https://medicaex.com/businesswire/guardant-health-to-showcase-new-data-at-san-antonio-breast-cancer-symposium-2022-demonstrating-utility-of-its-blood-tests-for-advanced-stage-breast-cancer-patients/ 2022-12-01T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/GuardantHealthLogo_TM_RGB-2C-OLtLFF.jpeg https://medicaex.com/businesswire/avodah-welcomes-four-new-members-to-avodahmeds-medical-advisory-council/ 2022-12-01T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/AvodahMed_TM_Blue_Org_Nov_2022-Sg8FGT.jpeg https://medicaex.com/businesswire/new-crown-bioscience-publication-details-application-of-in-vitro-3d-organoids-with-matched-pdx-for-clinically-relevant-oncology-drug-development-2/ 2022-12-01T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Crown_Bioscience_Logo_-_TEAL-rjvzIn.jpeg https://medicaex.com/businesswire/obio-appoints-new-chair-and-members-to-plan-for-the-future-of-the-healthcare-innovation-sector/ 2022-12-01T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/OBIO-Logo-300dpi-CQpLGZ.jpeg https://medicaex.com/businesswire/surgical-innovation-associates-sia-announces-definitive-agreement-to-be-acquired-by-integra-lifesciences-2/ 2022-12-01T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/SIA_Mark_-_Heal_Today_Strong_Tomorrow-mYRVRH.jpeg https://medicaex.com/businesswire/charles-river-launches-endosafe-nexus-200-emphasizes-critical-importance-of-smart-automation-for-endotoxin-detection-2/ 2022-12-01T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/charles_river_logo-U6ZFJX.jpeg https://medicaex.com/businesswire/wise-receives-fda-clearance-for-its-wise-cortical-strip-bringing-neuromonitoring-to-the-next-level/ 2022-12-01T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/WCS_002-l2hzw3.jpeg https://medicaex.com/businesswire/hologic-ranked-1-for-mammography-system-performance-and-customer-satisfaction-for-10th-consecutive-year/ 2022-12-01T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Hologic_Main_Logo_Small_White_cropped-j2xxOl.jpeg https://medicaex.com/businesswire/bioaffinity-technologies-presents-proprietary-cancer-therapeutic-research-at-joint-ascb-embo-meeting/ 2022-12-01T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/bioAfinity_logo-gPZaGh.jpeg https://medicaex.com/businesswire/surgical-innovation-associates-sia-announces-definitive-agreement-to-be-acquired-by-integra-lifesciences/ 2022-12-01T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/SIA_Mark_-_Heal_Today_Strong_Tomorrow-Sf68gh.jpeg https://medicaex.com/businesswire/dch-health-selects-healthtrust-for-supply-chain-resiliency-and-group-purchasing-services/ 2022-12-01T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/HealthTrust_Logo_horiz_CMYK-g8J4Fy.jpeg https://medicaex.com/businesswire/charles-river-launches-endosafe-nexus-200-emphasizes-critical-importance-of-smart-automation-for-endotoxin-detection/ 2022-12-01T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/charles_river_logo-v9wwUS.jpeg https://medicaex.com/businesswire/new-crown-bioscience-publication-details-application-of-in-vitro-3d-organoids-with-matched-pdx-for-clinically-relevant-oncology-drug-development/ 2022-12-01T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Crown_Bioscience_Logo_-_TEAL-YIYBms.jpeg https://medicaex.com/businesswire/august-bioservices-closes-65m-series-b/ 2022-12-01T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/AUG_BIO_LOGO_final_TM_FINAL_NEW-p16KNt.jpeg https://medicaex.com/businesswire/recode-therapeutics-appoints-trisha-millican-to-board-of-directors/ 2022-12-01T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/ReCode_Logo_Primary_Web402000px-Wtfw1k.jpeg https://medicaex.com/businesswire/aldeyra-therapeutics-announces-positive-primary-vitreoretinal-lymphoma-pre-nda-meeting-with-the-fda/ 2022-12-01T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/ALDX_logo_JPEG-pzhC2Q.jpeg https://medicaex.com/businesswire/generate-biomedicines-uses-ai-to-create-proteins-that-have-never-existed-2/ 2022-12-01T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/generate-bio-logo-rgb-black-1Df5HB.jpeg https://medicaex.com/businesswire/abcellera-and-rallybio-announce-strategic-alliance-to-discover-develop-and-commercialize-novel-antibody-based-therapeutics-for-rare-diseases-4/ 2022-12-01T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Press_Release_Logo-t817E4.jpeg https://medicaex.com/businesswire/alnylam-ranks-1-on-boston-globes-top-places-to-work-list-for-2022-2/ 2022-12-01T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Alnylam_Corporate_Logo-ZKgsfW.jpeg https://medicaex.com/businesswire/akili-announces-adhd-expert-dr-scott-kollins-to-join-as-chief-medical-officer-3/ 2022-12-01T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Kollins_headshot-wYtoau.jpeg https://medicaex.com/businesswire/deciphera-pharmaceuticals-inc-to-present-at-the-jmp-securities-hematology-and-oncology-summit-2/ 2022-12-01T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/dcph-logo-registered-rgb-W4a0Ck.jpeg https://medicaex.com/businesswire/generate-biomedicines-uses-ai-to-create-proteins-that-have-never-existed/ 2022-12-01T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/generate-bio-logo-rgb-black-ykUuzQ.jpeg https://medicaex.com/businesswire/catheter-precisions-vivo-system-used-in-more-than-800-procedures-in-leading-u-s-and-european-hospitals-2/ 2022-12-01T12:12:07+00:00 https://medicaex.com/businesswire/akili-announces-adhd-expert-dr-scott-kollins-to-join-as-chief-medical-officer-2/ 2022-12-01T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Kollins_headshot-xp5ffO.jpeg https://medicaex.com/businesswire/catheter-precisions-vivo-system-used-in-more-than-800-procedures-in-leading-u-s-and-european-hospitals/ 2022-12-01T12:12:06+00:00 https://medicaex.com/businesswire/alnylam-ranks-1-on-boston-globes-top-places-to-work-list-for-2022/ 2022-12-01T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Alnylam_Corporate_Logo-bZfXUW.jpeg https://medicaex.com/businesswire/akili-announces-adhd-expert-dr-scott-kollins-to-join-as-chief-medical-officer/ 2022-12-01T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Kollins_headshot-r1niP5.jpeg https://medicaex.com/businesswire/deciphera-pharmaceuticals-inc-to-present-at-the-jmp-securities-hematology-and-oncology-summit/ 2022-12-01T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/dcph-logo-registered-rgb-samdcZ.jpeg https://medicaex.com/businesswire/phi-delta-chi-announces-second-1m-pledge-to-st-jude-childrens-research-hospital/ 2022-12-01T12:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/SJ_FullVert_RGB-zMQIu1.jpeg https://medicaex.com/businesswire/abcellera-and-rallybio-announce-strategic-alliance-to-discover-develop-and-commercialize-novel-antibody-based-therapeutics-for-rare-diseases-3/ 2022-12-01T12:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/Press_Release_Logo-sF9K7A.jpeg https://medicaex.com/businesswire/greenwich-lifesciences-extends-lock-up-of-directors-and-officers-to-end-of-2023-2/ 2022-12-01T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/GLSI-logo-U0MHyr.jpeg https://medicaex.com/businesswire/vizient-medical-device-tech-watch-highlights-data-to-help-reduce-readmission-rates-in-heart-failure-patients-surveys-intraoperative-imaging-modalities-2/ 2022-12-01T11:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/Vizient_Logo_V2-7mJ0Km.jpeg https://medicaex.com/businesswire/vizient-medical-device-tech-watch-highlights-data-to-help-reduce-readmission-rates-in-heart-failure-patients-surveys-intraoperative-imaging-modalities/ 2022-12-01T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/Vizient_Logo_V2-hykFyr.jpeg https://medicaex.com/businesswire/greenwich-lifesciences-extends-lock-up-of-directors-and-officers-to-end-of-2023/ 2022-12-01T11:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/GLSI-logo-D6qmzl.jpeg https://medicaex.com/businesswire/cardior-welcomes-dr-orly-vardeny-as-permanent-guest-to-the-board-2/ 2022-12-01T10:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-cardior-mesh-green-RGB_300dpi-t5DbKp.jpeg https://medicaex.com/businesswire/cardior-welcomes-dr-orly-vardeny-as-permanent-guest-to-the-board/ 2022-12-01T10:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/logo-cardior-mesh-green-RGB_300dpi-TYUIbF.jpeg https://medicaex.com/businesswire/abcellera-and-rallybio-announce-strategic-alliance-to-discover-develop-and-commercialize-novel-antibody-based-therapeutics-for-rare-diseases-2/ 2022-12-01T09:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/AbCellera_Full_Colour_RGB_1-KagNsT.jpeg https://medicaex.com/businesswire/spectrumxs-hand-sanitiser-approved-for-nhs-supply-chains-nhs-supplier-list-2/ 2022-12-01T09:12:05+00:00 https://medicaex.com/businesswire/abcellera-and-rallybio-announce-strategic-alliance-to-discover-develop-and-commercialize-novel-antibody-based-therapeutics-for-rare-diseases/ 2022-12-01T09:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/AbCellera_Full_Colour_RGB_1-KOg67L.jpeg https://medicaex.com/businesswire/spectrumxs-hand-sanitiser-approved-for-nhs-supply-chains-nhs-supplier-list/ 2022-12-01T09:12:03+00:00 https://medicaex.com/businesswire/babyl-novo-nordisk-partner-to-provide-an-innovative-approach-to-diabetes-awareness-and-care-in-rwanda-2/ 2022-12-01T08:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/12/BYLN_Logo_FC_Landscape_377x177_RGB-PR-uGrnMP.jpeg https://medicaex.com/businesswire/babyl-novo-nordisk-partner-to-provide-an-innovative-approach-to-diabetes-awareness-and-care-in-rwanda/ 2022-12-01T08:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/BYLN_Logo_FC_Landscape_377x177_RGB-PR-gxKY8t.jpeg https://medicaex.com/businesswire/benevolentai-to-present-at-41st-annual-j-p-morgan-healthcare-conference-2/ 2022-12-01T06:12:27+00:00 https://medicaex.com/businesswire/benevolentai-to-present-at-41st-annual-j-p-morgan-healthcare-conference/ 2022-12-01T06:12:04+00:00 https://medicaex.com/businesswire/innate-pharma-to-present-adenosine-franchise-iph5201-and-iph5301-at-esmo-io-2022/ 2022-12-01T06:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/INNATEvertnoirDS-kFZeOy.jpeg https://medicaex.com/businesswire/iveric-bio-announces-pricing-of-300-million-public-offering-of-common-stock-2/ 2022-12-01T05:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Iveric_Bio_Logo-ZZEclR.jpeg https://medicaex.com/businesswire/iveric-bio-announces-pricing-of-300-million-public-offering-of-common-stock/ 2022-12-01T05:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/Iveric_Bio_Logo-RFSU4X.jpeg https://medicaex.com/businesswire/oceanside-ca-ahf-to-shame-gilead-with-world-aids-day-protest-dec-1/ 2022-12-01T03:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/Screen_Shot_2022-11-29_at_4.47.03_PM-QOnY3v.jpeg https://medicaex.com/businesswire/liminatus-pharma-llc-and-iris-acquisition-corp-to-combine-to-incorporate-and-accelerate-much-needed-cancer-treatments-2/ 2022-12-01T02:12:09+00:00 https://medicaex.com/businesswire/aura-biosciences-announces-pricing-of-public-offering-of-common-stock-2/ 2022-12-01T02:12:08+00:00 https://medicaex.com/businesswire/miami-fl-ahf-shames-gilead-with-protest-on-world-aids-day-dec-1/ 2022-12-01T02:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/GileadGREED1-RKNajn.jpeg https://medicaex.com/businesswire/aura-biosciences-announces-pricing-of-public-offering-of-common-stock/ 2022-12-01T02:12:04+00:00 https://medicaex.com/businesswire/liminatus-pharma-llc-and-iris-acquisition-corp-to-combine-to-incorporate-and-accelerate-much-needed-cancer-treatments/ 2022-12-01T02:12:04+00:00 https://medicaex.com/businesswire/washington-d-c-ahf-shames-gilead-with-world-aids-day-protest-dec-1st/ 2022-12-01T02:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/Screen_Shot_20221129-Te3Nr2.jpeg https://medicaex.com/businesswire/ferring-receives-u-s-fda-approval-for-rebyota-fecal-microbiota-live-jslm-a-novel-first-in-class-microbiota-based-live-biotherapeutic-2/ 2022-12-01T01:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/Rebyota_Logo_4C_with_live_type_ALTERNATE_R3_OL-fY3gaW.jpeg https://medicaex.com/businesswire/adicet-bio-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/ 2022-12-01T01:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/adicet_logo_500x300_2800229_2800429-mO1TkM.jpeg https://medicaex.com/businesswire/navidea-biopharmaceuticals-files-appeal-in-crg-case-2/ 2022-12-01T01:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/navidea_cmyk-A9xn6w.jpeg https://medicaex.com/businesswire/ahf-to-shame-gilead-with-nationwide-protests-on-world-aids-day/ 2022-12-01T01:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/Gileadgreed_copy-NJ6s8v.jpeg https://medicaex.com/businesswire/ferring-receives-u-s-fda-approval-for-rebyota-fecal-microbiota-live-jslm-a-novel-first-in-class-microbiota-based-live-biotherapeutic/ 2022-12-01T01:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/12/Rebyota_Logo_4C_with_live_type_ALTERNATE_R3_OL-gATfCT.jpeg https://medicaex.com/businesswire/adicet-bio-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/ 2022-12-01T01:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/adicet_logo_500x300_2800229_2800429-zjKeKo.jpeg https://medicaex.com/businesswire/navidea-biopharmaceuticals-files-appeal-in-crg-case/ 2022-12-01T01:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/navidea_cmyk-QT6cFG.jpeg https://medicaex.com/businesswire/viiv-healthcare-unveils-a-new-global-study-revealing-three-quarters-of-people-believe-there-are-still-negative-perceptions-when-it-comes-to-people-living-with-hiv-2/ 2022-12-01T00:12:07+00:00 https://medicaex.com/businesswire/viiv-healthcare-unveils-a-new-global-study-revealing-three-quarters-of-people-believe-there-are-still-negative-perceptions-when-it-comes-to-people-living-with-hiv/ 2022-12-01T00:12:03+00:00 https://medicaex.com/businesswire/enter-to-win-family-fun-for-four-at-detroit-lions-football-game/ 2022-12-01T00:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/12/Logo_Final_with_UHSM_tag-707K3g.jpeg https://medicaex.com/businesswire/sqz-biotechnologies-announces-strategic-prioritization-of-sqz-enhanced-antigen-presenting-cells-program-armon-sharei-to-step-down-as-chief-executive-officer-2/ 2022-11-30T22:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/SQZ_Logo-Medium-ZviS4k.jpeg https://medicaex.com/businesswire/innoviva-announces-fda-acceptance-and-priority-review-of-new-drug-application-for-sulbactam-durlobactam-sul-dur-2/ 2022-11-30T22:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/INVA_Logo-LLPKaV.jpeg https://medicaex.com/businesswire/honest-company-ceo-and-cfo-to-present-at-morgan-stanley-global-consumer-retail-conference-on-december-7-2022/ 2022-11-30T22:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/12/Honest_logo-PqFHeu.jpeg https://medicaex.com/businesswire/paysign-inc-to-present-at-the-d-a-davidson-fintech-and-payments-spotlight-conference/ 2022-11-30T22:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Paysign_Primary_Logo_4C_RGB-yXfJaC.jpeg https://medicaex.com/businesswire/sqz-biotechnologies-announces-strategic-prioritization-of-sqz-enhanced-antigen-presenting-cells-program-armon-sharei-to-step-down-as-chief-executive-officer/ 2022-11-30T22:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/SQZ_Logo-Medium-YwkXo1.jpeg https://medicaex.com/businesswire/innoviva-announces-fda-acceptance-and-priority-review-of-new-drug-application-for-sulbactam-durlobactam-sul-dur/ 2022-11-30T22:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/12/INVA_Logo-rOqODb.jpeg https://medicaex.com/businesswire/iveric-bio-announces-proposed-offering-of-common-stock-2/ 2022-11-30T21:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/12/Iveric_Bio_Logo-HQvGWm.jpeg https://medicaex.com/businesswire/aura-biosciences-announces-proposed-public-offering-of-common-stock-2/ 2022-11-30T21:12:10+00:00 https://medicaex.com/businesswire/aurinia-announces-the-great-britain-marketing-authorization-of-lupkynis-voclosporin-for-the-treatment-of-lupus-nephritis-2/ 2022-11-30T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/aurina_logo-wTCHCd.jpeg https://medicaex.com/businesswire/exelixis-to-present-at-the-virtual-jmp-securities-hematology-and-oncology-summit-on-december-7-2022-2/ 2022-11-30T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/12/exelixis_id_rgb_2c-RXc0Wj.jpeg https://medicaex.com/businesswire/quidelortho-to-host-investor-day-on-december-13-2022-4/ 2022-11-30T21:12:09+00:00 https://medicaex.com/businesswire/nautilus-inc-completes-refinancing-of-existing-term-loan-enhancing-its-liquidity-position-and-increasing-the-total-credit-facility-to-130-million/ 2022-11-30T21:12:08+00:00 https://medicaex.com/businesswire/quidelortho-to-host-investor-day-on-december-13-2022-3/ 2022-11-30T21:12:07+00:00 https://medicaex.com/businesswire/momentum-at-south-bay-for-rehabilitation-and-nursing-earns-industry-quality-award-3/ 2022-11-30T21:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/12/Momentum_logo-O0fPbb.jpeg https://medicaex.com/businesswire/quidelortho-to-host-investor-day-on-december-13-2022-2/ 2022-11-30T21:12:06+00:00